Shroom News,Spotlight Stock Cybin Files for Two Extra International Patents for its Research Phase Programs By Dennis Mutua August 20, 2021 Life sciences company focused on progressing psychedelics therapeutics by utilizing proprietary drug discovery platforms and unique delivery mechanisms Cybin Inc. (NEO: CYBN) (NYSE: CYBN) has filed for two additional international...
Psychedelic Stocks,Shroom News Core One Labs Acquires Frontier Mycology For CAD 7.5 Million By Dennis Mutua August 19, 2021 Life sciences company focused on bringing psychedelic medicine to market through delivery of novel delivery systems Core One Labs Inc. (CSE: COOL) (OTCMKTS: CLABF) announced having completed the acquisition of Frontier Mycology Co...
Psychedelic Stocks,Shroom News NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation By Dennis Mutua August 18, 2021 Biotechnology company specializing in clinical research to develop potential clinical treatment and wellness products to address mental illness conditions and weight management conditions NeonMind Biosciences Inc. (CSE: NEON) (OTC...
Psychedelic Stocks,Shroom News PsyBio Submits Patent Application For Methylated Trypatamines and Associated Analogs By Dennis Mutua August 17, 2021 Biotechnology company specializing in developing psychoactive compounds aimed at treating mental health conditions and disorders PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) has filed a patent application with the United ...
Psychedelic Stocks,Shroom News Atai Launches Revixia Life Sciences Which Will Develop Therapies to Treat Mental Health Conditions By Dennis Mutua August 13, 2021 Clinical-stage biopharmaceutical company seeking to transform he treatment of mental health conditions Atai Life Sciences (ATAI) announced having launched Revixia Life Sciences, as its wholly owned subsidiary. Revixia will be e...
Psychedelic Stocks,Shroom News Wesana Health Starts Animal Study For Traumatic Brain Injury Treatment By Dennis Mutua August 12, 2021 Emerging life sciences company specializing in developing and delivering psychedelic therapies to treat traumatic brain injuries Wesana Health Holdings Inc. (CSE: WESA) (OTCQB: WSNAF) announced having commenced the studies of func...
Psychedelic Stocks,Shroom News Dr. Robert Dworking Appointed by MindMed to Scientific Advisory Board By Dennis Mutua August 11, 2021 Psychedelic medicine biotech company developing psychedelic inspired medicine and therapies MindMed Inc. (MNMD) has appointed Dr. Robert H. Dworking to its scientific advisory board. Dr. Robert Dworking has a spent over three d...
Psychedelic Stocks,Shroom News Clerkenwell Partners With Transpharmation to Conduct Psychedelics Clinical Trials in Europe By Dennis Mutua August 10, 2021 UK based mental health company focused on conducting clinical research support services and psychedelic assisted therapies Clerkenwell Health announced having partnered with fellow UK based company Transpharmation to conduct psych...